Loomis, Sayles & Company
PAHC icon

Loomis, Sayles & Company’s Phibro Animal Health PAHC Stock Holding History

Loomis, Sayles & Company’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-520
Closed -$17K – 696
2019
Q1 		$17K Hold
520
– – ﹤0.01% 676
2018
Q4 		$17K Sell
520
-226
-30% -$8.53K ﹤0.01% 734
2018
Q3 		$32K Hold
746
– – ﹤0.01% 669
2018
Q2 		$34K Sell
746
-236
-24% -$10.4K ﹤0.01% 678
2018
Q1 		$39K Sell
982
-51
-5% -$1.89K ﹤0.01% 626
2017
Q4 		$35K Buy
1,033
+362
+54% +$12.9K ﹤0.01% 664
2017
Q3 		$25K Buy
671
+384
+134% +$14.4K ﹤0.01% 728
2017
Q2 		$11K Hold
287
– – ﹤0.01% 797
2017
Q1 		$8K Hold
287
– – ﹤0.01% 826
2016
Q4 		$8K Sell
287
-74
-20% -$2.02K ﹤0.01% 859
2016
Q3 		$10K Hold
361
– – ﹤0.01% 767
2016
Q2 		$7K Sell
361
-312
-46% -$6.51K ﹤0.01% 802
2016
Q1 		$18K Buy
673
+601
+835% +$17.2K ﹤0.01% 738
2015
Q4 		$2K Buy
+72
New +$2.31K ﹤0.01% 993

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Loomis, Sayles & Company's PAHC Position: Q2 2019 in Review

Loomis, Sayles & Company sold out of Phibro Animal Health (PAHC) in Q2 2019, closing a stake of 520 shares — an estimated $17K sold.

Loomis, Sayles & Company first reported a position in PAHC in Q4 2015 and held it in 14 quarters. The position peaked at $39K in Q1 2018. 168 funds tracked by Wall St. Rank hold PAHC as of Q2 2019.

  • Loomis, Sayles & Company reported no remaining Phibro Animal Health position as of Q2 2019 after selling out during the quarter.
  • Loomis, Sayles & Company sold 520 Phibro Animal Health shares in Q2 2019, an estimated $17K.
  • Loomis, Sayles & Company first reported a position in Phibro Animal Health in Q4 2015 and held it in 14 quarters.
  • Loomis, Sayles & Company's Phibro Animal Health position peaked at $39K in Q1 2018.
  • 168 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2019.

Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.